Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Benton

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Blood|February 2, 2017
FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemiaJo Ishizawa, Eiji Sugihara, Shinji Kuninaka, et al.
Leukemia & Lymphoma|January 18, 2018
Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemiaPrajwal Boddu, Hagop Kantarjian, Farhad Ravandi, et al.
Journal of Bacteriology|April 28, 2001
Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureusF S Kaczmarek, R P Zaniewski, T D Gootz, et al.
Cancer|April 24, 2018
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panelsCourtney D DiNardo, Mark J Routbort, Sarah A Bannon, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Blood Advances|January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosisPrajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
American Journal of Hematology|July 31, 2016
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyNicholas J Short, Christopher B Benton, Hsiang-Chun Chen, et al.
Blood|March 2, 2017
More than 1 <i>TP53</i> abnormality is a dominant characteristic of pure erythroid leukemiaGuillermo Montalban-Bravo, Christopher B Benton, Sa A Wang, et al.
American Journal of Hematology|December 23, 2016
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitorNicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Bone Marrow Transplantation|April 14, 2015
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantationMarina Konopleva, Christopher B Benton, Peter F Thall, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Blood|February 2, 2017
FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemiaJo Ishizawa, Eiji Sugihara, Shinji Kuninaka, et al.
Leukemia & Lymphoma|January 18, 2018
Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemiaPrajwal Boddu, Hagop Kantarjian, Farhad Ravandi, et al.
Journal of Bacteriology|April 28, 2001
Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureusF S Kaczmarek, R P Zaniewski, T D Gootz, et al.
Cancer|April 24, 2018
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panelsCourtney D DiNardo, Mark J Routbort, Sarah A Bannon, et al.
Cancer|February 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemiaChristopher B Benton, Prajwal C Boddu, Courtney D DiNardo, et al.
Blood Advances|January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosisPrajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
American Journal of Hematology|July 31, 2016
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyNicholas J Short, Christopher B Benton, Hsiang-Chun Chen, et al.
Blood|March 2, 2017
More than 1 <i>TP53</i> abnormality is a dominant characteristic of pure erythroid leukemiaGuillermo Montalban-Bravo, Christopher B Benton, Sa A Wang, et al.
American Journal of Hematology|December 23, 2016
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitorNicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Bone Marrow Transplantation|April 14, 2015
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantationMarina Konopleva, Christopher B Benton, Peter F Thall, et al.
Pageof 7